Biotech and Pharmaceuticals

Trump’s Pharmaceutical Tariff Threat Dims as Pfizer Deal Reassures Drugmakers: What It Means for the Industry
On September 30, 2025, President Donald Trump made headlines by shaking hands with Pfizer’s CEO, Albert Bourla, to announce a ... Read more

Trump Proposes 100% Tariff on Branded Drugs: What It Means for Pharma Companies and Consumers
President Donald Trump recently declared that starting October 1, the U.S. will impose a 100% tariff on all branded and ... Read more

Eli Lilly’s Obesity Pill Beats Novo Nordisk’s Oral Diabetes Drug in Groundbreaking Head-to-Head Trial
Eli Lilly recently announced exciting results for its new diabetes pill, orforglipron. In a recent study, this medication outperformed Novo ... Read more

Eli Lilly Invests $5 Billion in New Virginia Facility to Enhance Production of Targeted Cancer Drugs and Innovative Treatments
Eli Lilly recently announced an impressive $5 billion investment to build a new manufacturing facility in Goochland County, Virginia. This ... Read more